GABRIEL DEVIVO: Open Payments
NPI 1457989428 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$134 in 7 payments from 7 companies in 2025. Trend: 2023 $37 · 2024 $164 · 2025 $134
Food & beverage: $134
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: CAPLYTA, INGREZZA, Jornay PM, The Cologuard Plus Collection Kit, VAXNEUVANCE, Saxenda, UZEDY.
Industry payments across MI — which companies pay providers there.
